Edgewater Capital Partners Announces Partnership with CBCC Global Research
Cleveland, OH – May 27, 2025 – Edgewater Capital Partners (“Edgewater”), a Cleveland, Ohio-based private equity firm, has partnered with the shareholders and management team of CBCC Global Research, a multi-national clinical contract research organization (“CRO”) with deep experience in designing and managing clinical trials across a range of critical therapeutic areas, including oncology, CNS, and ophthalmology. Based in Bakersfield, California with additional operations in Ahmedabad, India, CBCC Global Research provides end-to-end clinical CRO services — spanning clinical study design, trial recruitment and site management, biostatistics and data analysis, regulatory strategy and medical writing — across Phase I–IV clinical trials.
“We are excited to begin this next stage of our growth with Edgewater,” said Manoj Vyas, CEO of CBCC Global Research. “We share a mutual vision on how to continue developing CBCC Global Research into a leading partner for our clients within our focused therapeutic areas. Edgewater’s willingness to invest in top people, technology, and infrastructure, combined with their deep understanding of the life sciences and clinical development landscape, makes them the ideal partner for CBCC Global Research’s next stage of growth.”
“CBCC Global Research has earned a reputation as a trusted partner in the pharmaceutical development ecosystem, distinguished by their deep therapeutic area experience and unwavering commitment to customer support, quality and regulatory excellence,” said Pete Ostergard, Managing Partner at Edgewater. “Our investment reflects our belief in the strength of their leadership, differentiated clinical trial capabilities, and multi-national infrastructure and site network. We look forward to building on CBCC Global Research’s momentum.”
Calfee, Halter, & Griswold LLP served as legal counsel to Edgewater Capital Partners. Western & Southern Financial Group provided debt financing for the transaction. Edgemont Capital Partners served as CBCC Global Research’s exclusive financial advisor. Stradling Yocca Carlson & Rauth LLP served as legal counsel to CBCC Global Research.
About CBCC Global Research
Headquartered in Bakersfield, California with additional operations in Ahmedabad, India, CBCC Global Research is a leading, multi-national clinical contract research organization with deep experience in designing and managing clinical trials across a range of therapeutic areas, including oncology, CNS, and ophthalmology. CBCC Global Research provides end-to-end CRO services — spanning clinical study design, project management, data analysis, regulatory strategy and medical writing — across Phase I–IV clinical trials.
About Edgewater Capital Partners
Headquartered in Cleveland, Ohio, Edgewater Capital Partners is a sector-focused private equity firm investing in lower middle-market performance materials and services businesses. The firm has extensive experience investing in the people, technology, and infrastructure to accelerate the growth trajectory of life sciences, specialty industrials, advanced materials, and specialty chemicals businesses. Over twenty-five years of industry-specific investing has allowed the firm to develop a deep understanding of the complexities and nuances common to these businesses.